Efficacy of Lu AF35700 in Patients With Early-in-disease or Late-in-disease Treatment-resistant Schizophrenia ( Anew )
- Registry ID
- EUCTR2017-000788-34
- Source registry
- EUCTR
- Status
- Completed
- Phase
- PHASE2
- Sponsor
- H. Lundbeck A/S
- Start date
- 2017-10-11
- Completion date
- 2019-02-05
- Last update
- 2026-08-16
Conditions
- Treatment-Resistant Schizophrenia
Summary
This study evaluates the efficacy of 10 mg/day Lu AF35700 on symptoms of schizophrenia in patients with early-in-disease (ED) or late-in-disease (LD) treatment-resistant schizophrenia (TRS)
Locations
- , , UK
- , , Bulgarian Drug Agency
View on source registry